B Cell Lymphoma
Showing 1 - 25 of 47
Venetoclax Tablets Crushed and Dissolved Into a Solution
Not yet recruiting
- Hematologic Malignancy
- +18 more
- 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Nov 8, 2023
Factors of CMV Reactivation in Patients Receiving of CAR-T Cells
Not yet recruiting
- Cytomegalovirus Infections
- +2 more
- (no location specified)
Sep 22, 2023
CAR, B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Suzhou (ThisCART19A with Dose Level 1, ThisCART19A with Dose Level
Recruiting
- CAR
- +2 more
- ThisCART19A with Dose Level 1
- ThisCART19A with Dose Level 2
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jan 18, 2023
B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)
Recruiting
- B Cell Lymphoma
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 3, 2023
CB-Long-Term Safety Study (CB-LTSS)
Enrolling by invitation
- Lymphoma, Non-Hodgkin
- +7 more
- Allogeneic CAR-T therapy
-
Irvine, California
- +3 more
Nov 18, 2022
Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)
Recruiting
- Nasopharyngeal Carcinoma
- +8 more
-
Springdale, ArkansasHighlands Oncology
Nov 11, 2022
B Cell Lymphoma, Acute Lymphoblastic Leukemia, Pediatric, Lymphoma Trial in Stanford (Fludarabine, Cyclophosphamide, Autologous
Suspended
- B Cell Lymphoma
- +2 more
- Fludarabine
- +2 more
-
Stanford, CaliforniaStanford Medical Center
Sep 8, 2022
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,
Recruiting
- Lymphoma, Non-Hodgkin
- +6 more
- CB-010
- +2 more
-
Scottsdale, Arizona
- +7 more
Aug 19, 2022
B Cell Lymphoma Trial in Tel-Aviv (Nivolumab Injection [Opdivo])
Recruiting
- B Cell Lymphoma
- Nivolumab Injection [Opdivo]
-
Tel-Aviv, IsraelTel-Aviv Sourasky Medicak center / BMT Unit
May 22, 2022
B-Cell Leukemia, B Cell Lymphoma Trial in Kunming (anti-CD19 UCAR-T injection)
Recruiting
- B-Cell Leukemia
- B Cell Lymphoma
- anti-CD19 UCAR-T injection
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Apr 21, 2022
CART Treatment, B Cell Lymphoma Trial in Tel-Aviv (Eltrombopag)
Recruiting
- CART Treatment
- B Cell Lymphoma
-
Tel-Aviv, IsraelTel-Aviv Sourasky Medicak center / BMT Unit
Apr 14, 2022
Advanced Solid Tumor, B Cell Lymphoma Trial in Brisbane (CN1)
Completed
- Advanced Solid Tumor
- B Cell Lymphoma
-
Brisbane, Queensland, AustriaMater Medical Centre
Oct 15, 2021
B Cell Lymphoma Trial in Kunming (CD19 and CD22 targeted prime CAR- T cells)
Recruiting
- B Cell Lymphoma
- CD19 and CD22 targeted prime CAR- T cells
-
Kunming, Yunnnan, China920th Hospital of Joint Logistics Support Force
Jul 30, 2021
B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Kunming (Anti-CD19 CAR-T Cells Injection)
Recruiting
- B Cell Lymphoma
- B-cell Acute Lymphoblastic Leukemia
- Anti-CD19 CAR-T Cells Injection
-
Kunming, Yunnan, ChinaKunming Yan'an Hospital
May 12, 2021
B Cell Leukemia, B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Guangzhou (CAR-ITNK cells)
Recruiting
- B Cell Leukemia
- +4 more
- CAR-ITNK cells
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Feb 6, 2021
B Cell Lymphoma, B Cell Leukemia, Myeloma Trial in Wenzhou (CAR-CD19 T cell, CAR-BCMA T cell, CAR-GPC3 T cell)
Active, not recruiting
- B Cell Lymphoma
- +5 more
- CAR-CD19 T cell
- +5 more
-
Wenzhou, Zhejiang, ChinaFirst Affiliated Hospital of Wenzhou Medical University
Oct 5, 2020
ALL, B Cell Lymphoma, Leukemia Trial run by the NCI (Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR))
Completed
- ALL
- +4 more
- Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 14, 2020
B Cell Lymphoma Trial in Guangzhou (CD19-targeting CAR T Cells infusion)
Withdrawn
- B Cell Lymphoma
- CD19-targeting CAR T Cells infusion
-
Guangzhou, Guangdong, ChinaCentral laboratory in Fuda cancer hospital
Jul 14, 2020
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
B Cell Leukemia, B Cell Lymphoma Trial in Philadelphia (CART-19)
Completed
- B Cell Leukemia
- B Cell Lymphoma
- CART-19
-
Philadelphia, PennsylvaniaCHOP - http://www.chop.edu/service/oncology/pediatric-cancer-res
Mar 2, 2020
B Cell Lymphoma Trial in Taiyuan, Tianjin (JHL1101, Rituximab)
Terminated
- B Cell Lymphoma
- JHL1101
- Rituximab
-
Taiyuan, Shanxi, China
- +1 more
Jan 6, 2020
B Cell Lymphoma, B Cell Leukemia Trial in Chengdu, Shanghai (CD20-CD19 cCAR T cells)
Unknown status
- B Cell Lymphoma
- B Cell Leukemia
- CD20-CD19 cCAR T cells
-
Chengdu, China
- +1 more
Nov 8, 2019
B Cell Lymphoma, B Cell Leukemia Trial in Chengdu, Shenzhen (CD19 CARvac T cells)
Unknown status
- B Cell Lymphoma
- B Cell Leukemia
- CD19 CARvac T cells
-
Chengdu, China
- +1 more
Nov 8, 2019